Derivative Of Yeast May Be A New Type Of Oral Treatment For Diabetics

Oh boy, oh boy, oh boy! We might just have a new type of oral diabetes treatment. It is derived from yeast and yes, that did make me giggle since yeast is in bread and bread is carbs and carbs turns to sugar and… you get my point.

It is called glucose tolerance factor, GTF, and is essential in understanding how your body builds a resistance to insulin and can use it an ineffective way at different parts of the day or in differing situations.

The results indicate that GTF acts similarly to insulin in the rats, lowering the level of glucose, and of LDL-cholesterol, (the “bad” cholesterol), and raising the level of HDL-cholesterol (the “good” cholesterol). GTF inhibited oxidation processes that can cause atherosclerosis and result in further complications of the disease like strokes and heart attacks. Moreover, when GTF is given at early stage of the disease, it could prevent or delay renal complications. GTF also helped to prevent cataracts and retinal damage. It was also found that GTF improves the effectiveness of injected insulin.

More research needs to be done but we have a strong start and great possibilities!

via Science Daily